Valbiotis SA reported earnings results for the full year ended December 31, 2023. For the full year, the company reported sales was EUR 6.81 million compared to EUR 2.81 million a year ago. Net loss was EUR 7.37 million compared to EUR 12.31 million a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.382 EUR | -2.26% | -11.18% | -72.36% |
Jun. 04 | Valbiotis Terminates Licensing, Supply Deal With Nestlé Unit | MT |
Jun. 04 | Valbiotis: share price plummets, Nestlé agreement terminated | CF |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-72.36% | 24.33M | |
+20.63% | 126B | |
+24.16% | 27.95B | |
-20.17% | 20.5B | |
-16.06% | 17.12B | |
-18.07% | 16.1B | |
-47.70% | 14.97B | |
+11.92% | 14.84B | |
+58.32% | 14.38B | |
+149.98% | 12.37B |
- Stock Market
- Equities
- ALVAL Stock
- News VALBIOTIS
- Valbiotis SA Reports Earnings Results for the Full Year Ended December 31, 2023